MDXXF (Pharmala Biotech Holdings) Accumulated Depreciation : $0.00 Mil (As of Feb. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Pharmala Biotech Holdings Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Pharmala Biotech Holdings's quarterly accumulated depreciation declined from Aug. 2024 ($-0.00 Mil) to Nov. 2024 ($0.00 Mil) but then stayed the same from Nov. 2024 ($0.00 Mil) to Feb. 2025 ($0.00 Mil).

Pharmala Biotech Holdings's annual accumulated depreciation increased from Aug. 2022 ($-0.00 Mil) to Aug. 2023 ($-0.00 Mil) and increased from Aug. 2023 ($-0.00 Mil) to Aug. 2024 ($-0.00 Mil).

Pharmala Biotech Holdings Accumulated Depreciation Historical Data

The historical data trend for Pharmala Biotech Holdings's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmala Biotech Holdings Accumulated Depreciation Chart

Pharmala Biotech Holdings Annual Data

Trend

Aug21

Aug22

Aug23

Aug24

Accumulated Depreciation

Pharmala Biotech Holdings Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	Aug24	Nov24	Feb25
Accumulated Depreciation	Get a 7-Day Free Trial										-	-	-	-	-

Pharmala Biotech Holdings Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Pharmala Biotech Holdings Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Pharmala Biotech Holdings's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmala Biotech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (OTCPK:MDXXF) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

MDMA:Canada

Address

1 Adelaide Street East, Suite 801, Toranto, ON, CAN, M5C 2V9

Website

https://www.pharmala.ca

Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. Its drug API is manufactured and encapsulated under GMP conditions. The company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations and royalties from licensing of its IP.